ATE420892T1 - Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg - Google Patents
Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionswegInfo
- Publication number
- ATE420892T1 ATE420892T1 AT01985449T AT01985449T ATE420892T1 AT E420892 T1 ATE420892 T1 AT E420892T1 AT 01985449 T AT01985449 T AT 01985449T AT 01985449 T AT01985449 T AT 01985449T AT E420892 T1 ATE420892 T1 AT E420892T1
- Authority
- AT
- Austria
- Prior art keywords
- proteins
- type iii
- secreted
- secretion
- flexneri
- Prior art date
Links
- 230000028327 secretion Effects 0.000 title abstract 4
- 241000606161 Chlamydia Species 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000009962 secretion pathway Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 11
- 102000004169 proteins and genes Human genes 0.000 abstract 10
- 241000607762 Shigella flexneri Species 0.000 abstract 3
- 230000002209 hydrophobic effect Effects 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 108010077805 Bacterial Proteins Proteins 0.000 abstract 1
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 1
- 241000498849 Chlamydiales Species 0.000 abstract 1
- 108010069584 Type III Secretion Systems Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 210000003934 vacuole Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25511800P | 2000-12-14 | 2000-12-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420892T1 true ATE420892T1 (de) | 2009-01-15 |
Family
ID=22966904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01985449T ATE420892T1 (de) | 2000-12-14 | 2001-12-13 | Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040131624A1 (de) |
| EP (1) | EP1341810B1 (de) |
| AT (1) | ATE420892T1 (de) |
| AU (1) | AU2002234796A1 (de) |
| DE (1) | DE60137449D1 (de) |
| HK (1) | HK1056369A1 (de) |
| WO (1) | WO2002048185A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040208890A1 (en) * | 2003-02-24 | 2004-10-21 | Institut Pasteur | Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| WO2005113791A2 (en) * | 2004-05-07 | 2005-12-01 | Johnson & Johnson Product Research And Development | Methods of identifying modulators of bacterial type iii protein secretion system |
| US8541007B2 (en) | 2005-03-31 | 2013-09-24 | Glaxosmithkline Biologicals S.A. | Vaccines against chlamydial infection |
| CA2563214A1 (en) * | 2006-10-12 | 2008-04-12 | Institut Pasteur | Shigella ipad protein and its use as a potential vaccine against shigella infection |
| CN110331157B (zh) * | 2019-08-02 | 2021-06-08 | 湖北大学 | 一种aep环化酶在大肠杆菌中的融合表达方法、aep环化酶环化能力鉴定方法及其应用 |
| CN110387366B (zh) * | 2019-08-02 | 2021-06-08 | 湖北大学 | 一种aep环化酶在毕赤酵母中的表达方法及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69841894D1 (de) * | 1997-11-21 | 2010-10-21 | Merck Serono Biodevelopment Sa | Äusseres Membranpolypeptid von Chlamydia pneumoniae sowie Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion |
| AU3243199A (en) * | 1998-03-05 | 1999-09-20 | University Of British Columbia, The | Methods for assaying type iii secretion inhibitors |
| US6822071B1 (en) * | 1998-11-12 | 2004-11-23 | The Regents Of The University Of California | Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease |
-
2001
- 2001-12-13 AU AU2002234796A patent/AU2002234796A1/en not_active Abandoned
- 2001-12-13 EP EP01985449A patent/EP1341810B1/de not_active Expired - Lifetime
- 2001-12-13 DE DE60137449T patent/DE60137449D1/de not_active Expired - Lifetime
- 2001-12-13 AT AT01985449T patent/ATE420892T1/de not_active IP Right Cessation
- 2001-12-13 US US10/450,380 patent/US20040131624A1/en not_active Abandoned
- 2001-12-13 WO PCT/IB2001/002808 patent/WO2002048185A2/en not_active Application Discontinuation
- 2001-12-14 US US10/014,670 patent/US20030045702A1/en not_active Abandoned
-
2003
- 2003-11-25 HK HK03108599.5A patent/HK1056369A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20030045702A1 (en) | 2003-03-06 |
| HK1056369A1 (en) | 2004-02-13 |
| EP1341810A2 (de) | 2003-09-10 |
| EP1341810B1 (de) | 2009-01-14 |
| WO2002048185A2 (en) | 2002-06-20 |
| AU2002234796A1 (en) | 2002-06-24 |
| DE60137449D1 (de) | 2009-03-05 |
| US20040131624A1 (en) | 2004-07-08 |
| WO2002048185A3 (en) | 2003-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McNamara et al. | A novel proline-rich protein, EspF, is secreted from enteropathogenic Escherichia coli via the type III export pathway | |
| Abrahmsen et al. | Analysis of signals for secretion in the staphylococcal protein A gene. | |
| Jonquieres et al. | Interaction between the protein InlB of Listeria monocytogenes and lipoteichoic acid: a novel mechanism of protein association at the surface of Gram‐positive bacteria | |
| Vanhove et al. | Outer membrane vesicles are vehicles for the delivery of V ibrio tasmaniensis virulence factors to oyster immune cells | |
| Zhang et al. | Identification and characterization of a novel protective antigen, Enolase of Streptococcus suis serotype 2 | |
| WO2005071088A3 (en) | Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof | |
| Silver et al. | Human Menkes X‐chromosome disease and the staphylococcal cadmium‐resistance ATPase: a remarkable similarity in protein sequences | |
| BRPI0413521A (pt) | seqüências de aminoácidos que facilitam a penetração de uma substáncia de interesse nas células e/ou no núcleos celulares | |
| Oomen et al. | Plant defensin AhPDF1. 1 is not secreted in leaves but it accumulates in intracellular compartments | |
| Habimana et al. | Positive role of cell wall anchored proteinase PrtP in adhesion of lactococci | |
| Chuzeville et al. | Antigen I/II encoded by integrative and conjugative elements of Streptococcus agalactiae and role in biofilm formation | |
| ATE420892T1 (de) | Sekretierte chlamydia polypeptide und verfahren zur identifizierung davon über ihre sekretion durch gramnegativen bakterientyp iii sekretionsweg | |
| Doyscher et al. | A canthamoeba feature a unique backpacking strategy to trap and feed on L isteria monocytogenes and other motile bacteria | |
| Samadder et al. | RETRACTED: The Escherichia coli ycbQRST operon encodes fimbriae with laminin‐binding and epithelial cell adherence properties in Shiga‐toxigenic E. coli O157: H7 | |
| Kassmannhuber et al. | Functional display of ice nucleation protein InaZ on the surface of bacterial ghosts | |
| Turner et al. | Peptide surface display and secretion using two LPXTG-containing surface proteins from Lactobacillus fermentum BR11 | |
| Bassford | Export of the periplasmic maltose-binding protein of Escherichia coli | |
| Velaithan et al. | Novel synthetic signal peptides for the periplasmic secretion of green fluorescent protein in Escherichia coli | |
| Burgos et al. | Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility | |
| Hsieh et al. | Omp52 is a growth-phase-regulated outer membrane protein of Leptospira santarosai serovar Shermani | |
| Vasilchenko et al. | Purification of a novel bacteriocin-like inhibitory substance produced by Enterococcus faecium ICIS 8 and characterization of its mode of action | |
| Brugerolle et al. | The rhizoplast of chrysomonads, a basal body–nucleus connector that polarises the dividing spindle | |
| Saier Jr et al. | Bacterial proteins with N-terminal leader sequences resembling mitochondrial targeting sequences of eukaryotes | |
| Sousa et al. | Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin | |
| WO2005085417A3 (de) | Bakterielles system zum proteintransport in eukaryontische zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |